# EDGAR Filing Document

**Accession Number:** 0001039803
**File Stem:** 0000910472-26-004804
**Filing Date:** 2026-3
**Character Count:** 26552
**Document Hash:** ccf99b8a0e885d07a2ae05e0473690e5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000910472-26-004804.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0000910472-26-004804

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260131

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**PERIOD START**: 20260731

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ProFunds
- **CENTRAL INDEX KEY:** 0001039803

**ORGANIZATION NAME:**
- **EIN:** 522035197
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-08239
- **FILM NUMBER:** 26817497

**BUSINESS ADDRESS:**
- **STREET 1:** 7272 WISCONSIN AVENUE
- **STREET 2:** 21ST FLOOR
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20814
- **BUSINESS PHONE:** 2404976428

**MAIL ADDRESS:**
- **STREET 1:** 7272 WISCONSIN AVENUE
- **STREET 2:** 21ST FLOOR
- **CITY:** BETHESDA
- **STATE:** MD
- **ZIP:** 20814

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** PROFUNDS
- **DATE OF NAME CHANGE:** 19970521

## Series and Classes Contracts Data

### PHARMACEUTICALS ULTRASECTOR PROFUND (Series ID: S000003093)

| Class ID   | Class Name                                         | Ticker Symbol   |
|:---|:---|:---|
| C000008401 | PHARMACEUTICALS ULTRASECTOR PROFUND INVESTOR CLASS | PHPIX           |
| C000008402 | PHARMACEUTICALS ULTRASECTOR PROFUND SERVICE CLASS  | PHPSX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** ProFunds

- **b. Investment Company Act file number:** 811-08239

- **c. CIK number of Registrant:** 0001039803

- **d. LEI of Registrant:** 549300HM4OOUYSE5DP77

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 7272 Wisconsin Avenue

  - **City:** Bethesda

  - **State:** MD

  - **Foreign country:** US

  - **Zip / Postal Code:** 20814

  - **Telephone number:** 240-497-6400

**Item A.2. Information about the Series.**

- **a. Name of Series:** PHARMACEUTICALS ULTRASECTOR PROFUND

- **b. EDGAR series identifier (if any):** S000003093

- **c. LEI of Series:** O4X73XQHFKFTUZE9BD44

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-07-31

- **b. Date as of which information is reported:** 2026-01-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $7967330.85

**Total Liabilities:** $4184304.58

**Net Assets:** $3783026.27

**Cash Not Reported:** $655.75

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000008401 | 15.01%               | 3.52%                | -2.46%               |
| Class ID C000008402 | 14.96%               | 3.42%                | -2.51%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $13580.66                | $233812.87                                 |
| Month 2  | $107242.65               | $-44375.45                                 |
| Month 3  | $-6084.59                | $-53994.80                                 |

**Designated Index Information**

- **Index Name:** Dow Jones U.S. Select Pharmaceuticals Index

- **Index Identifier:** DJSPHM

### Schedule of Portfolio Investments

| Name                                | Title                                         | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| ANI Pharmaceuticals Inc.            | ANI Pharmaceuticals, Inc.                     | CUSIP: 00182C103<br>LEI: 5493000T6CXTND40YH31 | Long             | EC               | CORP              | US        |       704 | NS      | $57622.40     | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Alumis Inc                          | Alumis, Inc.                                  | CUSIP: 022307102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1017 | NS      | $24926.67     | 0.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Amneal Pharmaceuticals Inc          | Amneal Pharmaceuticals, Inc.                  | CUSIP: 03168L105<br>LEI: 549300VV176ZO5WQHZ61 | Long             | EC               | CORP              | US        |      4729 | NS      | $64692.72     | 1.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Amphastar Pharmaceuticals Inc       | Amphastar Pharmaceuticals, Inc.               | CUSIP: 03209R103<br>LEI: 54930055TH0ZLSAQMJ38 | Long             | EC               | CORP              | US        |      1897 | NS      | $50251.53     | 1.33%             |  |  |  | No            |                  1 | On Loan: No      |
| Amylyx Pharmaceuticals Inc          | Amylyx Pharmaceuticals, Inc.                  | CUSIP: 03237H101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4364 | NS      | $62361.56     | 1.65%             |  |  |  | No            |                  1 | On Loan: No      |
| Aquestive Therapeutics Inc          | Aquestive Therapeutics, Inc.                  | CUSIP: 03843E104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      6279 | NS      | $18523.05     | 0.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Arvinas Inc                         | Arvinas, Inc.                                 | CUSIP: 04335A105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4362 | NS      | $58363.56     | 1.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Axsome Therapeutics Inc.            | Axsome Therapeutics, Inc.                     | CUSIP: 05464T104<br>LEI: 549300EXGR0XLRJEIB95 | Long             | EC               | CORP              | US        |       387 | NS      | $71304.75     | 1.88%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                 | PHPIX_SPSIPH_GOLDMAN                          | CUSIP: N/A<br>LEI: N/A                        | Long             | DE               |  | US        |       335 | OU      | $-36685.91    | -0.97%            |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | PHPIX_SPSIPH_GOLDMAN                          | CUSIP: N/A<br>LEI: N/A                        | Short            | DE               |  | US        |      -106 | OU      | $7376.40      | 0.19%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | PHPIX_SPSIPH_UBS                              | CUSIP: N/A<br>LEI: N/A                        | Long             | DE               |  | US        |       211 | OU      | $-19953.29    | -0.53%            |  |  |  | No            |                  2 | On Loan: No      |
| Bristol-Myers Squibb Company        | Bristol-Myers Squibb Company                  | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |      1127 | NS      | $62041.35     | 1.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical Inc.       | Collegium Pharmaceutical, Inc.                | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |      1182 | NS      | $54277.44     | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Corcept Therapeutics Inc.           | Corcept Therapeutics, Inc.                    | CUSIP: 218352102<br>LEI: 529900EO9LUTFMZ7FF90 | Long             | EC               | CORP              | US        |       677 | NS      | $26991.99     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| CorMedix Inc.                       | CorMedix, Inc.                                | CUSIP: 21900C308<br>LEI: 5299006YIA3L0MBW8358 | Long             | EC               | CORP              | US        |      4387 | NS      | $34043.12     | 0.90%             |  |  |  | No            |                  1 | On Loan: —       |
| Crinetics Pharmaceuticals Inc.      | Crinetics Pharmaceuticals, Inc.               | CUSIP: 22663K107<br>LEI: 549300Q1CNFXK5P31D28 | Long             | EC               | CORP              | US        |      1201 | NS      | $59977.94     | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Definium Therapeutics Inc.          | Definium Therapeutics, Inc.                   | CUSIP: 24477V105<br>LEI: 549300QY8KN1O6RPFJ13 | Long             | EC               | CORP              | US        |      4664 | NS      | $78728.32     | 2.08%             |  |  |  | No            |                  1 | On Loan: No      |
| Edgewise Therapeutics Inc.          | Edgewise Therapeutics, Inc.                   | CUSIP: 28036F105<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2432 | NS      | $68460.80     | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Elanco Animal Health Inc            | Elanco Animal Health, Inc.                    | CUSIP: 28414H103<br>LEI: 549300SHPNDCE059M934 | Long             | EC               | CORP              | US        |      2711 | NS      | $65280.88     | 1.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Enliven Therapeutics Inc            | Enliven Therapeutics, Inc.                    | CUSIP: 29337E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2178 | NS      | $57608.10     | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Esperion Therapeutics Inc           | Esperion Therapeutics, Inc.                   | CUSIP: 29664W105<br>LEI: 549300OFU56UKEWVUS92 | Long             | EC               | CORP              | US        |     15075 | NS      | $51104.25     | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Evolus Inc                          | Evolus, Inc.                                  | CUSIP: 30052C107<br>LEI: 549300VYQRYBQOT8V419 | Long             | EC               | CORP              | US        |      4490 | NS      | $21058.10     | 0.56%             |  |  |  | No            |                  1 | On Loan: No      |
| Eyepoint Inc.                       | EyePoint Pharmaceuticals, Inc.                | CUSIP: 30233G209<br>LEI: 549300QE1RU34T50MR69 | Long             | EC               | CORP              | US        |      3453 | NS      | $46684.56     | 1.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Harmony Biosciences Holdings Inc    | Harmony Biosciences Holdings, Inc.            | CUSIP: 413197104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1470 | NS      | $53684.40     | 1.42%             |  |  |  | No            |                  1 | On Loan: No      |
| Harrow Inc                          | Harrow, Inc.                                  | CUSIP: 415858109<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1150 | NS      | $47081.00     | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Indivior Pharmaceuticals Inc.       | Indivior Pharmaceuticals, Inc.                | CUSIP: 45579U109<br>LEI: 213800V3NCQTY7IED471 | Long             | EC               | CORP              | US        |      1629 | NS      | $57634.02     | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Innoviva Inc                        | Innoviva, Inc.                                | CUSIP: 45781M101<br>LEI: 549300ACOX4QTBES6535 | Long             | EC               | CORP              | US        |      2800 | NS      | $56000.00     | 1.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                   | Johnson & Johnson                             | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |       280 | NS      | $63630.00     | 1.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Zevra Therapeutics Inc              | Zevra Therapeutics, Inc.                      | CUSIP: 488445206<br>LEI: 254900CU6T74V18Y1W18 | Long             | EC               | CORP              | US        |      3932 | NS      | $35388.00     | 0.94%             |  |  |  | No            |                  1 | On Loan: No      |
| Lenz Therapeutics Inc               | LENZ Therapeutics, Inc.                       | CUSIP: 52635N103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1869 | NS      | $29567.58     | 0.78%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Incorporated | Ligand Pharmaceuticals, Inc.                  | CUSIP: 53220K504<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |       314 | NS      | $60319.40     | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co.                     | Eli Lilly & Company                           | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |        58 | NS      | $60154.70     | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Liquidia Corporation                | Liquidia Corporation                          | CUSIP: 53635D202<br>LEI: 549300O826O5VQJTG707 | Long             | EC               | CORP              | US        |      1767 | NS      | $74903.13     | 1.98%             |  |  |  | No            |                  1 | On Loan: No      |
| MBX Biosciences, Inc.               | MBX Biosciences, Inc.                         | CUSIP: 55287L101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      2003 | NS      | $73810.55     | 1.95%             |  |  |  | No            |                  1 | On Loan: No      |
| Maze Therapeutics Inc               | Maze Therapeutics, Inc.                       | CUSIP: 578784100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1295 | NS      | $56436.10     | 1.49%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co., Inc                    | Merck & Company, Inc.                         | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |       591 | NS      | $65169.57     | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Nektar Therapeutics                 | Nektar Therapeutics                           | CUSIP: 640268306<br>LEI: 5299005I24806IOIYE03 | Long             | EC               | CORP              | US        |      1000 | NS      | $37330.00     | 0.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Nuvation Bio Inc                    | Nuvation Bio, Inc.                            | CUSIP: 67080N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      7365 | NS      | $38592.60     | 1.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Ocular Therapeutix Inc              | Ocular Therapeutix, Inc.                      | CUSIP: 67576A100<br>LEI: 529900ABAWFXOHSIHG03 | Long             | EC               | CORP              | US        |      3750 | NS      | $34275.00     | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Omeros Corp                         | Omeros Corporation                            | CUSIP: 682143102<br>LEI: 549300CJWLXX2MXVVV71 | Long             | EC               | CORP              | US        |      3019 | NS      | $35292.11     | 0.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                        | Organon & Company                             | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |      8042 | NS      | $68678.68     | 1.82%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacira Biosciences Inc              | Pacira BioSciences, Inc.                      | CUSIP: 695127100<br>LEI: 549300P56LERYBDHCF69 | Long             | EC               | CORP              | US        |      2293 | NS      | $47098.22     | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc.                         | Pfizer, Inc.                                  | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |      2240 | NS      | $59225.60     | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Phathom Pharmaceuticals Inc         | Phathom Pharmaceuticals, Inc.                 | CUSIP: 71722W107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3421 | NS      | $46765.07     | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Phibro Animal Health Corporation    | Phibro Animal Health Corporation              | CUSIP: 71742Q106<br>LEI: 549300U24SP4AF2JUX52 | Long             | EC               | CORP              | US        |      1343 | NS      | $53921.45     | 1.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Prestige Consumer Healthcare Inc    | Prestige Consumer Healthcare, Inc.            | CUSIP: 74112D101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       941 | NS      | $60666.27     | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Rapport Therapeutics Inc            | Rapport Therapeutics, Inc.                    | CUSIP: 75383L102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1926 | NS      | $51250.86     | 1.35%             |  |  |  | No            |                  1 | On Loan: No      |
| Septerna Inc.                       | Septerna, Inc.                                | CUSIP: 81734D104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1042 | NS      | $24320.28     | 0.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Supernus Pharmaceuticals, Inc       | Supernus Pharmaceuticals, Inc.                | CUSIP: 868459108<br>LEI: 549300GRM36VBKISYJ58 | Long             | EC               | CORP              | US        |      1251 | NS      | $60248.16     | 1.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Tarsus Pharmaceuticals Inc          | Tarsus Pharmaceuticals, Inc.                  | CUSIP: 87650L103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |       710 | NS      | $45823.40     | 1.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Terns Pharmaceuticals Inc.          | Terns Pharmaceuticals, Inc.                   | CUSIP: 880881107<br>LEI: 254900S1ZDQMF4MYP709 | Long             | EC               | CORP              | US        |      1294 | NS      | $44772.40     | 1.18%             |  |  |  | No            |                  1 | On Loan: No      |
| Trevi Therapeutics Inc              | Trevi Therapeutics, Inc.                      | CUSIP: 89532M101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      4075 | NS      | $42665.25     | 1.13%             |  |  |  | No            |                  1 | On Loan: No      |
| Ventyx Biosciences Inc.             | Ventyx Biosciences Inc                        | CUSIP: 92332V107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3368 | NS      | $46983.60     | 1.24%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                         | Viatris, Inc.                                 | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |      4977 | NS      | $65148.93     | 1.72%             |  |  |  | No            |                  1 | On Loan: No      |
| Xeris Biopharma Holdings Inc        | Xeris Biopharma Holdings, Inc.                | CUSIP: 98422E103<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      8320 | NS      | $61235.20     | 1.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Zoetis Inc.                         | Zoetis, Inc.                                  | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |       489 | NS      | $61036.98     | 1.61%             |  |  |  | No            |                  1 | On Loan: No      |
| AGPXX                               | Invesco Government & Agency Portfolio         | CUSIP: 825252885<br>LEI: N/A                  | Long             | STIV             | RF                | US        |     34370 | NS      | $34369.50     | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Avadel Pharmaceuticals PLC          | Avadel Pharmaceuticals plc                    | CUSIP: G29687103<br>LEI: 549300E27PTSG2RHC762 | Long             | EC               | CORP              | IE        |      2688 | NS      | $57926.40     | 1.53%             |  |  |  | No            |                  1 | On Loan: No      |
| Jazz Pharmaceuticals PLC            | Jazz Pharmaceuticals plc                      | CUSIP: G50871105<br>LEI: 635400GAUMJCLEZRRV50 | Long             | EC               | CORP              | IE        |       350 | NS      | $57571.50     | 1.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                  | Royalty Pharma plc                            | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | US        |      1509 | NS      | $62895.12     | 1.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Theravance Biopharma Inc            | Theravance Biopharma, Inc.                    | CUSIP: G8807B106<br>LEI: 5493007VTSXP4Z6MIW52 | Long             | EC               | CORP              | KY        |      1409 | NS      | $26686.46     | 0.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Perrigo Company PLC                 | Perrigo Company plc                           | CUSIP: G97822103<br>LEI: 549300IFOQS6R1QLY196 | Long             | EC               | CORP              | IE        |      4271 | NS      | $60690.91     | 1.60%             |  |  |  | No            |                  1 | On Loan: No      |
| N/A                                 | HSBC SECURITIES (USA), INC.  3.55 , 2/02/2026 | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |    170000 | PA      | $170000.00    | 4.49%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | NATWEST MARKETS PLC  3.53 , 2/02/2026         | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |    177000 | PA      | $177000.00    | 4.68%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | ROYAL BANK OF CANADA  3.45 , 2/02/2026        | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |     94000 | PA      | $94000.00     | 2.48%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | SOCIETE' GENERALE  3.55 , 2/02/2026           | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |    221000 | PA      | $221000.00    | 5.84%             |  |  |  | No            |                  2 | On Loan: No      |
| N/A                                 | UMB FINANCIAL CORP. B 3.4 , 2/02/2026         | CUSIP: N/A<br>LEI: N/A                        | Long             | RA               | CORP              | US        |    101000 | PA      | $101000.00    | 2.67%             |  |  |  | No            |                  2 | On Loan: No      |
| Wave Life Sciences Ltd.             | WaVe Life Sciences Ltd.                       | CUSIP: Y95308105<br>LEI: 54930070006GPKFYZ813 | Long             | EC               | CORP              | US        |      2854 | NS      | $36930.76     | 0.98%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-01-31

**Name of Applicant:** Pharmaceuticals UltraSector ProFund

**Signature:** Rebecca Colvin

**Name of Signer:** Rebecca Colvin

**Title:** Treasurer and Principal Financial Officer